Pilaralisib Completed Phase 1 Trials for Cancer (Solid Tumors) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01436565A Study of Investigational SAR256212 in Combination With SAR245408 in Patients With Solid Tumor Cancers